Embelin, a small molecule quinone with a co-clinical power for castrate-resistant prostate cancer

Embelin, a small molecule quinone with a co-clinical power for castrate-resistant prostate cancer

Bibliographic Details
Main Author:	Dr. Radhika J Poojari
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-08-01
Series:	Frontiers in Pharmacology
Subjects:	Gene Therapy Castrate Resistant Prostate Cancer Embelin CO-CLINICAL integrated human-mouse cross-species
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00184/full

Similar Items

The Application of Embelin for Cancer Prevention and Therapy
by: Jeong-Hyeon Ko, et al.
Published: (2018-03-01)

Antioxidant and inhibition of senescence effects of embelin
by: Jin Jung Ahn, et al.
Published: (2018-03-01)

In Vitro Analysis of the Antioxidant and Antiviral Activity of Embelin Against Herpes Simplex Virus-1
by: Tony Elias, et al.
Published: (2021-02-01)

Computational studies reveal mechanism by which quinone derivatives can inhibit SARS-CoV-2. Study of embelin and two therapeutic compounds of interest, methyl prednisolone and dexamethasone
by: Francesco Caruso, et al.
Published: (2020-12-01)

Embelin Restores Carbapenem Efficacy against NDM-1-Positive Pathogens
by: Nian-Zhi Ning, et al.
Published: (2018-01-01)

Efficient Multicomponent Synthesis of Diverse Antibacterial Embelin-Privileged Structure Conjugates
by: Pedro Martín-Acosta, et al.
Published: (2020-07-01)

Embelin impairs the accumulation and activation of MDSCs in colitis-associated tumorigenesis
by: Ting Wu, et al.
Published: (2018-11-01)

<b>Synthesis and characterization of zinc(II) and copper(II) complexes of embelin</b>
by: J.K. Cherutoi, et al.
Published: (2005-12-01)

Embelin can protect mice from thioacetamide-induced acute liver injury
by: Huafeng Wang, et al.
Published: (2019-10-01)

Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?
by: Magdalena Schrank, et al.
Published: (2020-01-01)

Embelin as a Novel Inhibitor of PKC in the Prevention of Platelet Activation and Thrombus Formation
by: Jiun Yi Li, et al.
Published: (2019-10-01)

Surgical castration efficiently delays the time of starting a systemic chemotherapy in castration-resistant prostate cancer patients refractory to initial androgen-deprivation therapy
by: Minyong Kang, et al.
Published: (2015-12-01)

Embelin Protects Against Acute Pentylenetetrazole-Induced Seizures and Positively Modulates Cognitive Function in Adult Zebrafish
by: Uday Praful Kundap, et al.
Published: (2019-10-01)

Antioxidant Properties of Embelin in Cell Culture. Electrochemistry and Theoretical Mechanism of Scavenging. Potential Scavenging of Superoxide Radical through the Membrane Cell
by: Francesco Caruso, et al.
Published: (2020-05-01)

Design, synthesis and α-glucosidase inhibition study of novel embelin derivatives
by: Xiaole Chen, et al.
Published: (2020-01-01)

Effect of Embelin on Inhibition of Cell Growth and Induction of Apoptosis in k562 Cell Line
by: Zynab Bargeshadi, et al.
Published: (2018-01-01)

Self nano-emulsifying drug delivery system for Embelin: Design, characterization and in-vitro studies
by: Komal Parmar, et al.
Published: (2015-10-01)

Experimental study of apoptosis in the prostate tissue following castration
by: Y Doustar, et al.
Published: (2008-02-01)

Effects of the natural compounds embelin and piperine on the biofilm-producing property of Streptococcus mutans
by: Deepak Dwivedi, et al.
Published: (2016-01-01)

Prostate radiation in non-metastatic castrate refractory prostate cancer provides an interesting insight into biology of prostate cancer
by: Pascoe Abigail C, et al.
Published: (2012-03-01)

Amelioration of Cognitive Deficit by Embelin in a Scopolamine-Induced Alzheimer’s Disease-Like Condition in a Rat Model
by: Saatheeyavaane Bhuvanendran, et al.
Published: (2018-06-01)

Targeted delivery of embelin to cancer cells
by: Emjedi, Zaakiyah Z.
Published: (2015)

Impact of clinical trial participation on survival in patients with castration-resistant prostate cancer: a multi-center analysis
by: Kyo Chul Koo, et al.
Published: (2018-04-01)

Fabrication and evaluation of a medicated hydrogel film with embelin from Embelia ribes for wound healing activity
by: Hiral Shrimali, et al.
Published: (2019-12-01)

Embelin: an HPTLC method for quantitative estimation in five species of genus Embelia Burm. f.
by: K. P. Rini Vijayan, et al.
Published: (2021-02-01)

Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions
by: Caffo O, et al.
Published: (2016-12-01)

TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: T. N. Skvortsova, et al.
Published: (2017-01-01)

Darolutamide For Castration-Resistant Prostate Cancer
by: Bastos DA, et al.
Published: (2019-10-01)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
by: Lixin Mai, et al.
Published: (2020-12-01)

Embelin, a Potent Molecule for Alzheimer's Disease: A Proof of Concept From Blood-Brain Barrier Permeability, Acetylcholinesterase Inhibition and Molecular Docking Studies
by: Saatheeyavaane Bhuvanendran, et al.
Published: (2019-05-01)

EXPERIENCE WITH OCTREOTIDE IN PATIENTS WITH CASTRATION REFRACTORY PROSTATE CANCER
by: D. I. Ganov, et al.
Published: (2014-07-01)

EXPERIENCE WITH OCTREOTIDE IN PATIENTS WITH CASTRATION REFRACTORY PROSTATE CANCER
by: D. I. Ganov, et al.
Published: (2014-07-01)

Novel Strategies for Treating Castration-Resistant Prostate Cancer
by: David Ka-Wai Leung, et al.
Published: (2021-03-01)

Real-world experience with abiraterone in metastatic castration-resistant prostate cancer
by: Yasar Ahmed, et al.
Published: (2017-01-01)

Drug treatment opportunities of the elderly patients with the metastatic castration-resistant prostate cancer
by: V. A. Solodkiy, et al.
Published: (2017-04-01)

ROLE OF DEGARELIX (FIRMAGON) IN THE TREATMENT OF DISSEMINATED PROSTATE CANCER: CAN THE QUALITY OF CASTRATION THERAPY BE IMPROVED?
by: V. B. Matveev, et al.
Published: (2014-07-01)

ROLE OF DEGARELIX (FIRMAGON) IN THE TREATMENT OF DISSEMINATED PROSTATE CANCER: CAN THE QUALITY OF CASTRATION THERAPY BE IMPROVED?
by: V. B. Matveev, et al.
Published: (2014-07-01)

Predictors for progression of metastatic prostate cancer to castration-resistant prostate cancer in Indians
by: Sanjoy Kumar Sureka, et al.
Published: (2016-01-01)

Embelin Promotes Oncolytic Vaccinia Virus-Mediated Antitumor Immunity Through Disruption of IL-6/STAT3 Signaling in Lymphoma
by: Wang P, et al.
Published: (2020-02-01)

Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice
by: Geehyun Song, et al.
Published: (2013-09-01)

Cannot write session to /tmp/vufind_sessions/sess_fpg5unnrhek0graouroavs0aro